Health Condition 1: C531- Malignant neoplasm of exocervix
Conditions
Interventions
Intervention1: ISBT of dose 9 x 2: After EBRT patient will receive Interstitial brachytherapy of dose 9 Gy in 2 fractions
Control Intervention1: ISBT of dose 7 x 3: After EBRT patient will receive Ins
Sponsors
SVIMS
Eligibility
Inclusion criteria
Inclusion criteria: Histopathologically confirmed carcinoma of Uterine cervix Patients of age group 18 to 70 years. Patients with performance status of 0 to 2 Stage II B- III C with intact cervix. Patients with gross residual disease after EBRT not suitable for ICRT Distorted Geometry like narrow vagina and os not soundable Post hysterectomy Carcinoma vault Post supra cervical hysterectomy with carcinoma of cervical stump. Extensive para vaginal and distal vaginal involvement Patients who has given approved informed consent Post EBRT parametrial involvement of more than medial one third
Exclusion criteria
Exclusion criteria: Patients with distant metastasis Patients with prior EBRT and Brachytherapy to pelvis Patients with ECOG performance status of 3-4 Pregnant women and lactating mothers Patients who has not given informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumour ResponseTimepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Proctitis and CystitisTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactHenita Selvamary
Sri Venkateswara Institute of Medical Sciences
Outcome results
None listed